Cargando…
A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis
The major environmental risk factor for rheumatoid arthritis (RA) is smoking, which according to a widely accepted model induces protein citrullination in the lungs, triggering the production of anti-citrullinated protein antibodies (ACPA) and RA development. Nevertheless, some research findings do...
Autores principales: | Regueiro, Cristina, Rodriguez-Rodriguez, Luis, Lopez-Mejias, Raquel, Nuño, Laura, Triguero-Martinez, Ana, Perez-Pampin, Eva, Corrales, Alfonso, Villalba, Alejandro, Lopez-Golan, Yolanda, Abasolo, Lydia, Remuzgo-Martínez, Sara, Ortiz, Ana M., Herranz, Eva, Martínez-Feito, Ana, Conde, Carmen, Mera-Varela, Antonio, Balsa, Alejandro, Gonzalez-Alvaro, Isidoro, Ángel González-Gay, Miguel, Fernandez-Gutierrez, Benjamín, Gonzalez, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042270/ https://www.ncbi.nlm.nih.gov/pubmed/32098994 http://dx.doi.org/10.1038/s41598-020-60305-x |
Ejemplares similares
-
Publisher Correction: A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis
por: Regueiro, Cristina, et al.
Publicado: (2020) -
Improved classification of rheumatoid arthritis with a score including anti-acetylated ornithine antibodies
por: Rodriguez-Martínez, Lorena, et al.
Publicado: (2020) -
Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies
por: Regueiro, Cristina, et al.
Publicado: (2021) -
Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis
por: Hernández-Breijo, Borja, et al.
Publicado: (2021) -
Low Serum BAFF Concentration Is Associated with Response to TNF Inhibitors in Seropositive Patients with Rheumatoid Arthritis
por: Hernández-Breijo, Borja, et al.
Publicado: (2022)